Market Research Logo

Active Pharmaceutical Ingredient/ API Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone, Biosimilar) Drug (OTC, Rx), Therapy, and Region - Global Forecast to 2024

Active Pharmaceutical Ingredient/ API Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone, Biosimilar) Drug (OTC, Rx), Therapy, and Region - Global Forecast to 2024

“Increasing incidence of chronic diseases and technological advancements in API manufacturing are expected to drive the overall growth of the global APIs market.”
The global APIs market is estimated to reach USD 245.2 billion by 2024 from USD 182.2 billion in 2019, at a CAGR of 6.1% during the forecast period. The increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals are some of the major factors driving the growth of the global APIs market. On the other hand, the unfavorable drug price control policies across various countries and the increasing penetration of counterfeit drugs are expected to restrain the growth of this market in the coming years.

“The biotech APIs segment is expected to grow at the highest CAGR during the forecast period.”
On the basis of type of synthesis, the APIs market is categorized into synthetic APIs and biotech APIs. The synthetic APIs segment is estimated to account for the largest share in 2019. However, the biotech APIs segment is expected to grow at a higher rate over the forecast period. Factors such as growing demand of biotech drugs due to their specificity in action, advancements in biotechnology, increase in demand for monoclonal antibodies, and their similarity with the natural biological compounds found in the human body influence the growth of this segment.

“The monoclonal antibodies segment is expected to account for the largest share of the global biotech APIs market.”
Based on product, the biotech APIs market is segmented into monoclonal antibodies, hormones & growth factors, cytokines, fusion proteins, therapeutic enzymes, recombinant vaccines, and blood factors. In 2019, the monoclonal antibodies segment is estimated to account for the largest share of the biotech APIs market. Factors such as the increasing incidence of cancer, increasing investments in R&D, technological advances in genetic sequencing and target gene selection, and reduced side effects as compared to chemotherapy are responsible for driving this market.

“North America to dominate the market during the forecast period.”
In 2019, North America is expected to dominate the market, followed by Europe. The major factors driving the overall growth of the APIs market in this region include the growing incidence of preventable chronic diseases, increasing government focus on generic drugs, rising demand for biologics and specialty drugs, and technological advancements in the manufacturing processes of APIs. This market segment is expected to grow at a modest rate due to a combination of economic and healthcare severity measures and the introduction of low-cost, generic versions of branded drugs.

The primary interviews conducted for this report can be categorized as follows:
By Company Type - Tier 1: 37%, Tier 2: 22%, Tier 3: 41%
By Designation - C-level: 25%, D-level: 20%, Others: 55%
By Region - North America: 40%, Europe: 27%, Asia: 20%, RoW: 13%

List of Companies Profiled in the Report
Pfizer, Inc. (US)
Novartis AG (Switzerland)
Sanofi (France)
Boehringer Ingelheim (Germany)
Bristol-Myers Squibb (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (US)
GlaxoSmithKline plc (UK)
Merck & Co., Inc. (US)
AbbVie Inc. (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
AstraZeneca plc (UK)

Research Coverage:
This report provides a picture of the global APIs market. It aims at estimating the size and future growth potential of the market across different segments, such as type, type of manufacturer, type of synthesis, type of drug, therapeutic application, and region. Furthermore, the report also includes an in-depth competitive analysis of key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them the closest approximations of the revenue numbers for the overall APIs market and its subsegments. Also, this report will help stakeholders to better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY SOURCES
      • PRIMARY SOURCES
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • MARKET SHARE ESTIMATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • ACTIVE PHARMACEUTICAL INGREDIENTS: MARKET OVERVIEW
    • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
    • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER
    • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS
    • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG
    • GEOGRAPHIC SNAPSHOT: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table INDICATIVE LIST OF DRUGS GOING GENERIC IN 2018
        • Table INDICATIVE LIST OF BIOLOGICS THAT GAINED REGULATORY APPROVAL IN THE US IN 2017-2018
      • RESTRAINTS
      • OPPORTUNITIES
        • Table INDICATIVE LIST OF BIOSIMILARS THAT GAINED US REGULATORY APPROVAL IN 2018
      • CHALLENGES
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
    • INTRODUCTION
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
    • INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS
      • GROWING NUMBER OF NEW MOLECULAR ENTITIES GAINING REGULATORY APPROVAL TO DRIVE MARKET GROWTH
        • Table INDICATIVE LIST OF NEW MOLECULAR ENTITIES THAT GAINED US FDA APPROVAL IN 2018
        • Table LIST OF MAJOR DRUGS SET TO LOSE PATENT PROTECTION IN 2018
        • Table INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2024 (USD BILLION)
    • GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS
      • GOVERNMENT INITIATIVES SUPPORTING THE ADOPTION OF GENERIC DRUGS TO BOOST MARKET GROWTH
        • Table GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER
    • INTRODUCTION
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
    • CAPTIVE API MANUFACTURERS
      • HIGH MANUFACTURING FLEXIBILITY AND ASSURANCE OF PRODUCT QUALITY HAVE DRIVEN FOCUS ON CAPTIVE MANUFACTURING
        • Table CAPTIVE API MANUFACTURERS MARKET, BY REGION, 2017-2024 (USD BILLION)
    • MERCHANT API MANUFACTURERS
      • Table LIST OF SIGNIFICANT CMO/CDMO FACILITY EXPANSIONS
      • Table MERCHANT API MANUFACTURERS MARKET, BY REGION, 2017-2024 (USD BILLION)
      • MERCHANT API MANUFACTURERS MARKET, BY TYPE
        • Table MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table MERCHANT INNOVATIVE API MANUFACTURERS MARKET, BY REGION, 2017-2024 (USD BILLION)
        • Table MERCHANT GENERIC API MANUFACTURERS MARKET, BY REGION, 2017-2024 (USD BILLION)
      • MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS
        • Table MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS 2017-2024 (USD BILLION)
        • Table MERCHANT SYNTHETIC API MANUFACTURERS MARKET, BY REGION, 2017-2024 (USD BILLION)
        • Table MERCHANT BIOTECH API MANUFACTURERS MARKET, BY REGION, 2017-2024 (USD BILLION)
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS
    • INTRODUCTION
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
    • SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS
      • Table SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2024 (USD BILLION)
      • SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
        • Table SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE 2017-2024 (USD BILLION)
        • Table INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2024 (USD BILLION)
        • Table GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2024 (USD BILLION)
    • BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS
      • Table TOP SELLING BIOLOGICS (2018)
      • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2024 (USD BILLION)
      • BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2024 (USD BILLION)
        • Table INDICATIVE LIST OF BIOSIMILARS THAT GAINED US FDA APPROVAL DURING 2017-2018
        • Table GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2024 (USD BILLION)
      • BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT 2017-2024 (USD BILLION)
        • Table INDICATIVE LIST OF MONOCLONAL ANTIBODIES THAT RECEIVED FDA APPROVAL IN 2018
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2017-2024 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY REGION, 2017-2024 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY REGION, 2017-2024 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY REGION, 2017-2024 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY REGION, 2017-2024 (USD MILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY REGION, 2017-2024 (USD MILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY REGION, 2017-2024 (USD MILLION)
      • BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2017-2024 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY REGION, 2017-2024 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY REGION, 2017-2024 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2017-2024 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY REGION, 2017-2024 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY REGION, 2017-2024 (USD MILLION)
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG
    • INTRODUCTION
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
    • PRESCRIPTION DRUGS
      • GROWING DISEASE PREVALENCE IS EXPECTED TO DRIVE THE PRESCRIPTION DRUGS MARKET
        • Table PRESCRIPTION DRUGS MARKET, BY REGION, 2017-2024 (USD BILLION)
    • OVER-THE-COUNTER DRUGS
      • SALES OF OTC DRUGS HAVE RISEN DUE TO INNOVATIONS, PROMOTION OF SELF-MEDICATION, AND INCREASED ACCESS
        • Table OVER-THE-COUNTER DRUGS MARKET, BY REGION, 2017-2024 (USD BILLION)
    • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY
      • LOW-TO-MODERATE POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS
      • POTENT-TO-HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS
        • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION
    • INTRODUCTION
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
    • COMMUNICABLE DISEASES
      • GLOBAL HEALTH IMPACT OF COMMUNICABLE DISEASES AND INCREASING ANTIMICROBIAL RESISTANCE-KEY MARKET DRIVERS
        • Table INDICATIVE LIST OF US FDA-APPROVED DRUGS FOR COMMUNICABLE DISEASES (2018)
        • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY REGION, 2017-2024 (USD BILLION)
    • ONCOLOGY
      • INCREASE IN GLOBAL SPENDING ON CANCER MEDICATION TO BOOST THE MARKET FOR THIS SEGMENT
        • Table INDICATIVE LIST OF US FDA-APPROVED DRUGS FOR ONCOLOGY (2018)
        • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY REGION, 2017-2024 (USD BILLION)
    • PAIN MANAGEMENT
      • INCREASING DEMAND FOR INNOVATIVE AND ADVANCED PAIN MEDICATIONS IS A MAJOR GROWTH DRIVER FOR THIS MARKET
        • Table INDICATIVE LIST OF US FDA-APPROVED DRUGS FOR PAIN MANAGEMENT (2018)
        • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY REGION, 2017-2024 (USD BILLION)
    • CARDIOVASCULAR DISEASES
      • GROWING INCIDENCE OF CARDIOVASCULAR DISEASES OWING TO SEDENTARY LIFESTYLES IS A MAJOR GROWTH DRIVER
        • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2017-2024 (USD BILLION)
    • DIABETES
      • HIGH GLOBAL PREVALENCE OF DIABETES TO DRIVE THE GROWTH OF THIS SEGMENT
        • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY REGION, 2017-2024 (USD BILLION)
    • RESPIRATORY DISEASES
      • HIGH GLOBAL PREVALENCE OF RESPIRATORY DISEASES TO DRIVE THE GROWTH OF THIS SEGMENT
        • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY REGION, 2017-2024 (USD BILLION)
    • OTHER THERAPEUTIC APPLICATIONS
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2017-2024 (USD BILLION)
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION
    • INTRODUCTION
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2017-2024 (USD BILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017-2024 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
      • Table NORTH AMERICA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table NORTH AMERICA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
      • Table NORTH AMERICA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2017-2024 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
      • US
        • Table INDICATIVE LIST OF RECENT FDA APPROVALS FOR DRUG DELIVERY PRODUCTS
        • Table US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
        • Table US: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table US: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table US: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table US: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
        • Table US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
        • Table US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
      • CANADA
        • Table CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
        • Table CANADA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table CANADA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table CANADA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table CANADA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
        • Table CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
        • Table CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
    • EUROPE
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017-2024 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
      • Table EUROPE: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table EUROPE: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
      • Table EUROPE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2017-2024 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
      • GERMANY
        • Table GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
        • Table GERMANY: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table GERMANY: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table GERMANY: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table GERMANY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
        • Table GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
        • Table GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
      • FRANCE
        • Table FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
        • Table FRANCE: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table FRANCE: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table FRANCE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table FRANCE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
        • Table FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
        • Table FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
      • UK
        • Table UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
        • Table UK: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table UK: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table UK: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table UK: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
        • Table UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
        • Table UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
      • ITALY
        • Table ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
        • Table ITALY: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table ITALY: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table ITALY: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table ITALY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
        • Table ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
        • Table ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
      • SPAIN
        • Table SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
        • Table SPAIN: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table SPAIN: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table SPAIN: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table SPAIN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
        • Table SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD MILLION)
        • Table SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
        • Table ROE: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table ROE: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table ROE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table ROE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
        • Table ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
        • Table ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
    • ASIA
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017-2024 (USD BILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
      • Table ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
      • Table ASIA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
      • JAPAN
        • Table JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
        • Table JAPAN: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table JAPAN: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table JAPAN: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table JAPAN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
        • Table JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
        • Table JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
      • CHINA
        • Table CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
        • Table CHINA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table CHINA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table CHINA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table CHINA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
        • Table CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
        • Table CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
      • INDIA
        • Table INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
        • Table INDIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table INDIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table INDIA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table INDIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
        • Table INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
        • Table INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
      • SOUTH KOREA
        • Table SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
        • Table SOUTH KOREA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table SOUTH KOREA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table SOUTH KOREA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table SOUTH KOREA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
        • Table SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
        • Table SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
      • REST OF ASIA
        • Table ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
        • Table ROA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table ROA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
        • Table ROA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table ROA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
        • Table ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
        • Table ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
        • Table ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
    • REST OF THE WORLD
      • Table ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2017-2024 (USD BILLION)
      • Table ROW: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table ROW: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
      • Table ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2017-2024 (USD BILLION)
      • Table ROW: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table ROW: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2024 (USD BILLION)
      • Table ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2017-2024 (USD BILLION)
      • Table ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2017-2024 (USD BILLION)
      • Table ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2017-2024 (USD BILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET PLAYER RANKING
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET PLAYER RANKING, 2018
    • COMPETITIVE LEADERSHIP MAPPING
      • VANGUARDS
      • DYNAMIC DIFFERENTIATORS
      • INNOVATORS
      • EMERGING PLAYERS
    • COMPETITIVE SITUATION AND TRENDS
      • PRODUCT LAUNCHES
        • Table PRODUCT LAUNCHES, 2016-2018
      • EXPANSIONS
        • Table EXPANSIONS, 2016-2018
      • ACQUISITIONS
        • Table ACQUISITIONS, 2015-2018
      • OTHER STRATEGIES
        • Table OTHER STRATEGIES, 2015-2018
  • COMPANY PROFILES
    • PFIZER, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • NOVARTIS AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SANOFI
      • BUSINESS OVERVIEW
        • Table EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF EUR TO USD)
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BOEHRINGER INGELHEIM
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BRISTOL-MYERS SQUIBB
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • TEVA PHARMACEUTICAL INDUSTRIES LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ELI LILLY AND COMPANY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • GLAXOSMITHKLINE PLC
      • BUSINESS OVERVIEW
        • Table EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF GBP TO USD)
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MERCK & CO., INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ABBVIE INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • F. HOFFMANN-LA ROCHE
      • BUSINESS OVERVIEW
        • Table EXCHANGE RATES (UTILIZED FOR THE CONVERSION OF CHF TO USD)
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ASTRAZENECA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report